Economists say estimates from the Bureau of Labor Statistics and other agencies are reliable, but they worry the quality of data is eroding.

A landmark Lancet analysis of more than 150,000 trial participants challenges decades of statin side-effect warnings and calls for updated drug labels grounded in randomized evidence. Study: ...

For instance, yearly reports of cognitive or memory problems were 0.2% among statin users and 0.2% among those on placebo. In other words, while some people may experience these symptoms during ...

Most people surveyed wouldn't be willing to take statins at their actual efficacy levels in primary prevention, according to a study with implications for shared decision-making. When informed about ...

A randomized clinical trial involving 958 older adults suggests that taking a daily multivitamin for two years may produce a small, statistically significant slowdown in two measures of biological ...

The majority of undesirable side effects linked to statin therapy are not supported by evidence from randomized, controlled trials, with just four of 66 possible side effects attributed to the drug ...

New research indicates that the majority of side-effects commonly linked to statins are not, in fact, caused by the medication itself. A comprehensive study, published in The Lancet, examined data ...

Clinical trial data showed that some side effects attributed to statins on product labels rose above the level of likely false discovery due to multiple comparisons. Statins contributed less than 0.1% ...

Share on Pinterest A major review has found that the majority of statin side effects are not scientifically backed. Image Credit: BSIP/Getty Images Most statin side effects listed on drug packaging ...

Patients worried about potential side effects of statins can rest easy, according to a new large-scale study: The vast majority of adverse effects listed on statin medications simply never occur. The ...

Discover how modern cardiovascular services protect your heart. Learn about expert cardiology care teams and preventative ...

Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today issued a call to action for American Heart Month emphasizing a ...